Trillium Renewable Chemicals | $13,000,000 | (May 7, 2026)
RadixArk | $100,000,000 | (May 7, 2026)
Astrada | $3,800,000 | (May 7, 2026)
Certified by Founder
Lodge
Avenue Therapeutics
start up
United States
- New York, NY
- 13/12/2021
- Unknown
- $2,000,000
Avenue Therapeutics, Inc. (NASDAQ: ATXI), a Fortress Biotech (NASDAQ: FBIO) Company, is a specialty pharmaceutical company.
Please be aware of Recruiting Fraud: https://www.avenuetx.com/beware-of-recruiting-fraud/
- Industry Biotechnology Research
- Website https://www.avenuetx.com/
- LinkedIn https://www.linkedin.com/company/avenue-therapeutics/
Related People
Lucy LuFounder
United States -
New York City Metropolitan Area
I am an executive of a development-stage biotech company. Prior to working in the biotech industry, I was a senior equity analyst covering small- to mid-cap biotechnology companies. My expertise includes strategic planning, clinical development, regulatory strategy, business development, biotech equity valuation, investor relations and capital markets.
XCaliber Health | $6,500,000 | (May 7, 2026)
Cytospire Therapeutics Ltd | $82,984,705 | (May 7, 2026)
QuantWare | $178,775,560 | (May 7, 2026)
MOSH | $13,000,000 | (May 7, 2026)
InstaSwitch | $4,700,000 | (May 7, 2026)
Smartness | $55,270,590 | (May 7, 2026)
Scout Space | $18,000,000 | (May 7, 2026)
Altara | $7,000,000 | (May 7, 2026)
District | $14,700,000 | (May 7, 2026)